Alexandra. Siegfried, et.al., IFIT2 is an effector protein of type I IFN-mediated amplification of lipopolysaccharide (LPS)-induced TNF-α secretion and LPS-induced endotoxin shock., Journal of immunology (Baltimore, Md. : 1950), 2013, 191

http://rdf.ncbi.nlm.nih.gov/pubmed/24014876

Alexandra. Siegfried, et.al., IFIT2 is an effector protein of type I IFN-mediated amplification of lipopolysaccharide (LPS)-induced TNF-α secretion and LPS-induced endotoxin shock., Journal of immunology (Baltimore, Md. : 1950), 2013, 191

pubmed

allele

http://purl.org/net/cito/citesAsAuthority

• Ifit2<tm1.1Ebsb>
  http://metadb.riken.jp/db/mgi_rdf/MGI:5430603

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• decreased tumor necrosis factor secretion_Ifit2<tm1.1Ebsb>/Ifit2<tm1.1Ebsb>
  http://metadb.riken.jp/0008561B6NCrl129P2CIfit2tm11EbsbIfit2tm11EbsbIfit2tm11EbsbIfit2tm11Ebsb
• increased susceptibility to bacterial infection induced morbidity/mortality_Ifit2<tm1.1Ebsb>/Ifit2<tm1.1Ebsb>
  http://metadb.riken.jp/0009788B6NCrl129P2CIfit2tm11EbsbIfit2tm11EbsbIfit2tm11EbsbIfit2tm11Ebsb
• decreased tumor necrosis factor secretion_Ifnar1<tm1Agt>/Ifnar1<tm1Agt>
  http://metadb.riken.jp/0008561B6129S2Ifnar1tm1AgtIfnar1tm1AgtIfnar1tm1AgtIfnar1tm1Agt
• decreased interleukin-6 secretion_Ifnar1<tm1Agt>/Ifnar1<tm1Agt>
  http://metadb.riken.jp/0008706B6129S2Ifnar1tm1AgtIfnar1tm1AgtIfnar1tm1AgtIfnar1tm1Agt
• increased susceptibility to bacterial infection induced morbidity/mortality_Ifnar1<tm1Agt>/Ifnar1<tm1Agt>
  http://metadb.riken.jp/0009788B6129S2Ifnar1tm1AgtIfnar1tm1AgtIfnar1tm1AgtIfnar1tm1Agt
• decreased circulating interleukin-6 level_Ifit2<tm1.1Ebsb>/Ifit2<tm1.1Ebsb>
  http://metadb.riken.jp/0008597B6NCrl129P2CIfit2tm11EbsbIfit2tm11EbsbIfit2tm11EbsbIfit2tm11Ebsb
• decreased circulating tumor necrosis factor level_Ifit2<tm1.1Ebsb>/Ifit2<tm1.1Ebsb>
  http://metadb.riken.jp/0008554B6NCrl129P2CIfit2tm11EbsbIfit2tm11EbsbIfit2tm11EbsbIfit2tm11Ebsb
• decreased circulating interleukin-1 beta level_Ifit2<tm1.1Ebsb>/Ifit2<tm1.1Ebsb>
  http://metadb.riken.jp/0008642B6NCrl129P2CIfit2tm11EbsbIfit2tm11EbsbIfit2tm11EbsbIfit2tm11Ebsb
• decreased interleukin-6 secretion_Ifit2<tm1.1Ebsb>/Ifit2<tm1.1Ebsb>
  http://metadb.riken.jp/0008706B6NCrl129P2CIfit2tm11EbsbIfit2tm11EbsbIfit2tm11EbsbIfit2tm11Ebsb
• decreased circulating interleukin-12b level_Ifit2<tm1.1Ebsb>/Ifit2<tm1.1Ebsb>
  http://metadb.riken.jp/0008648B6NCrl129P2CIfit2tm11EbsbIfit2tm11EbsbIfit2tm11EbsbIfit2tm11Ebsb

class

http://purl.org/net/cito/citesAsAuthority

• Ifit2<tm1.1Ebsb>
  http://metadb.riken.jp/db/mgi_rdf/MGI:5430603

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• increased susceptibility to bacterial infection induced morbidity/mortality in RBRC04021
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1013923
• decreased interleukin-6 secretion in RBRC04021
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1013919
• decreased tumor necrosis factor secretion in RBRC04021
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1013915